Details for New Drug Application (NDA): 016012
✉ Email this page to a colleague
NDA 016012 describes VIVACTIL, which is a drug marketed by Chartwell Rx and Teva Womens and is included in three NDAs. Additional details are available on the VIVACTIL profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Summary for 016012
| Tradename: | VIVACTIL |
| Applicant: | Teva Womens |
| Ingredient: | protriptyline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016012
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
